Well being expertise firm PicnicHealth introduced it’s transferring into the oncology area and teaming up with AstraZeneca to construct a registry to generate real-world information on breast most cancers.
The corporate says it’s going to work with individuals residing with most cancers to gather and construction their medical data information to advance oncology analysis utilizing sturdy datasets.
Moreover, the California-based firm introduced a multi-year partnership with biopharmaceutical big AstraZeneca to create a registry to generate longitudinal real-world information from consenting U.S. sufferers recognized with stage 1 to stage 3 breast most cancers.
The registry, which sufferers can at present enroll in, will manage their medical data right into a centralized portal and permit sufferers to contribute their de-identified information to breast most cancers analysis.
“We’re best-suited for companions that need to leverage our expertise working immediately with sufferers to develop richer, extra full datasets that supply a window into the affected person expertise for sufferers with early most cancers diagnoses. Since these sufferers are sometimes prone to survive their cancers or stay with most cancers for an prolonged time frame, working with these sufferers to develop datasets performs to our energy in affected person engagement and our skill to synthesize affected person data throughout care websites together with patient-reported outcomes,” Dr. Dan Drozd, chief medical officer at PicnicHealth, advised MobiHealthNews in an e mail.
THE LARGER TREND
In April, PicnicHealth introduced a partnership with pharma big Roche and its subsidiary Genentech to speed up neurological illness analysis by way of investments in real-world information. Roche deliberate to leverage PicnicHealth’s datasets for Alzheimer’s Illness, Alzheimer’s Illness-related dementias and myasthenia gravis, a persistent autoimmune dysfunction leading to weak spot of the skeletal muscle mass.
The identical month, it announced it would partner with world nonprofit firm CureDuchenne, which focuses on discovering a remedy for Duchenne muscular dystrophy. The pair would bolster real-world proof technology for the CureDuchenne Hyperlink platform.
Final yr, PicnicHealth scored $60 million in Series C funding, two years after it secured $35 million in equity financing.
The info firm additionally announced a partnership with world biopharmaceutical firm Bristol Myers Squibb to merge datasets to higher perceive sufferers with obstructive hypertrophic cardiomyopathy.
In 2021, PicnicHealth and Komodo Health shaped a partnership to collectively use their merchandise to create a real-world affected person information pool utilizing de-identified information from payers, suppliers, labs and digital well being data and supply that information to biopharmaceutical and tutorial communities.
